Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell type enhanced"	"Detected in many"	19	"Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4"					"Not detected"	"Not detected"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.4	0.0	2.2	0.0	1.4	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.1	5.0	0.2	1.5	0.0	0.0	0.0	6.0	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.3	0.6	21.4	0.5	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	1.2	258.2	0.0	1.1	13.3	0.0	5.7	0.0	648.3	0.0	3.0	3.0	0.2	0.9	5.7	0.0	2.8	0.0	41.6	0.0	0.0	8.4	0.0	1.3	0.0	115.4	108.6	0.0	2.2	375.2	0.0	73.1	0.0	0.0	0.1	2.8	0.7	0.1	2.9	0.0	80.4	0.3
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase, copper containing 2"	O75106	17	42844600-42850707	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 133.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 28.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1.0	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1.0	0.9	0.9	1.0	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1.0	1.3	1.0	1.7	0.7	6.5	0.9	1.0	1.0	0.9	1.2	1.6	0.9	0.1	0.0	4.0	0.0	0.0	0.6	0.0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2.0	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1.0	0.6	0.1	1.0	4.0	6.0	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1.0	0.0	0.0	0.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.5	0.9	0.2	0.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.4	28.8	0.7	0.0	0.0	0.3	0.1	0.2	0.7	0.0	0.8	0.1	0.0	0.0	0.6	0.8	3.3	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.2	0.6	0.0	0.9	2.1	2.7	1.4	0.0	0.0	0.0	0.5
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 70.4;Sertoli cells: 116.4;Smooth muscle cells: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enriched"	"Detected in some"	18	"ASC diff: 85.5"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	85.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.3	1.5	0.1	0.1	4.7	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3	3.0	8.9	0.8	0.0	2.6	0.0	3.2	0.0	1.4	3.4	0.0	0.0	0.1	0.0	0.1	3.8	4.7	0.0	0.0	0.2	0.1	2.6	0.2	1.1	0.0	1.1	0.0	0.0	22.7	3.0	2.1	3.1	0.5	3.3	0.0	0.0	0.4	0.1	0.0	70.4	0.7	0.5	116.4	56.5	0.9	0.7	1.6	0.2	0.0	0.0	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 649.9"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	85.8	44.1	0.0	1.4	2.6	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.5	0.0	0.0	3.9	4.8	0.0	0.1	0.0	1.0	4.3	5.7	0.2	0.0	17.7	1.0	5.6	17.7	1.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	6.8	3.0	2.4	0.0	0.5	0.0	0.0	0.6	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2	3.0	0.6	13.7	0.5	1.5	0.0	0.7	12.7	0.0	0.0	3.5	0.0	0.0	10.0	0.6	0.5	1.3	0.0	0.0	22.4	0.1	10.2	8.3	0.0	649.9	0.4	0.0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0.0	0.0	0.4	18.4	0.0	77.1	111.5	0.0	0.0	2.8	0.7	0.6	1.4	0.0	0.0	0.0	0.3
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.8	3.7	2.8	23.5	10.7	16.9	32.2	19.1	16.2	5.4	5.0	10.4	16.6	5.9	41.2	18.5	18.6	24.1	1.8	11.5	0.8	9.1	6.5	2.1	5.3	45.1	15.0	1.8	12.4	22.6	20.4	5.5	5.3	19.7	0.0	2.0	13.0	14.4	5.1	29.5	0.2	4.9	11.6	6.4	14.5	0.0	8.9	11.5	6.5	8.5	6.9	10.6	9.2	9.0	26.2	5.5	3.0	6.4	0.4	20.1	11.0	24.0	9.9	17.4	5.3	2.7	18.4	1.9	20.3	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0	0.0	14.6	4.5	19.1	12.9	13.8	27.7	25.5	2.7	6.8	71.5	9.8	137.8	8.3	48.8	3.2	3.5	16.9	0.0	70.1	162.1	52.1	34.2	10.3	49.9	16.5	41.3	41.2	6.7	1.3	5.7	23.0	2.8	64.1	2.8	36.9	62.9	60.3	26.6	59.4	16.4	11.4	25.8	16.5	11.6	5.5	9.7	259.5	7.5	11.3	28.6
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.8	3.5	11.9	6.0	6.2	8.4	7.9	6.9	6.1	8.4	8.6	3.0	2.3	6.8	4.1	11.5	5.5	7.9	7.9	8.8	9.3	7.6	3.9	13.5	4.0	3.5	7.7	20.5	14.0	7.7	7.4	7.2	6.6	9.6	9.9	3.1	4.9	69.8	6.3	2.4	2.8	14.1	13.7	5.5	2.5	6.4	12.0	10.1	5.8	5.6	2.1	11.3	7.3	3.6	12.5	10.2	4.1	25.5	8.3	13.8	7.9	6.5	14.5	12.4	28.6	4.0	10.7	19.5	10.2	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5	0.0	17.8	6.2	17.2	51.4	9.0	7.1	2.5	10.7	11.4	15.7	5.9	5.6	1.7	4.4	0.7	37.9	0.9	23.3	1.9	19.4	44.1	15.0	24.4	4.9	14.0	36.5	2.9	57.7	14.0	1.3	50.9	17.6	25.3	1.0	3.4	9.1	4.6	3.4	44.2	1.9	7.3	45.3	68.0	3.9	7.2	54.6	11.6	8.7	3.1	8.5
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904472-130186634	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Ito cells: 4.9;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 11.3;HSkMC: 7.4;TIME: 6.8;U-138 MG: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"	NA	NA					"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	11.7	1.6	7.0	2.7	8.9	0.3	5.7	0.4	10.4	12.5	1.7	2.1	0.0	1.5	4.2	1.6	1.8	2.6	7.2	3.0	4.8	2.2	1.0	4.8	4.6	1.4	2.1	8.9	1.1	1.1	2.1	0.9	5.6	1.0	1.4	1.6	6.3	1.3	1.8	2.2	2.8	1.3	5.2	1.5	1.9	1.5	1.9	2.1	0.0	2.9	1.3	1.3	3.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	12.7	11.3	1.0	2.8	0.1	0.4	0.4	0.0	0.1	0.0	0.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.7	5.6	0.4	1.2	0.0	0.0	7.4	0.0	0.1	1.1	0.6	3.0	0.0	0.0	1.8	4.9	0.0	0.0	0.0	0.6	0.0	1.2	0.4	5.4	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.2	1.1	0.2	0.4	6.8	13.6	2.8	0.1	1.8	0.0	0.0	0.0	0.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	8.9	0.4	10.4	4.8	2.2	2.1	8.9	1.0	2.1	8.9	0.6	0.0	0.0	0.5	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	2.3	0.0	0.0	2.0	1.4	0.0	0.0	4.9	1.8	0.0	1.1	0.0	3.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	6.5	2.5	1.4	0.6	0.3	0.3	0.0	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Enzymes, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 57.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	13.8	8.7	22.7	6.0	15.4	6.8	7.2	3.8	21.4	13.0	3.8	9.2	4.0	2.8	7.1	5.9	21.2	8.7	10.8	23.8	17.7	8.2	5.3	2.3	7.9	10.5	9.1	18.7	38.6	10.9	4.2	5.9	25.1	7.0	21.7	2.1	2.6	5.8	7.3	3.9	4.2	4.2	17.2	8.6	6.3	5.4	2.7	10.3	4.0	57.7	4.5	6.1	18.9	9.7	20.1	1.7	10.3	1.2	3.2	25.5	4.8	0.7	29.0	0.2	0.0	4.8	1.1	3.7	0.6	16.3	0.1	0.1	1.4	0.3	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.1	3.6	0.2	0.0	8.3	0.7	2.1	0.0	0.0	0.4	0.7	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	1.2	1.1	0.1	0.0	3.6	0.9	0.1	0.0	0.0	20.3	0.7	0.1	0.1	8.5	3.4	1.1	0.6	0.0	0.0	0.3	0.4	0.4	18.5	0.2	0.1	0.0	0.0	13.4	1.6	5.6	0.0	1.2	10.3	2.5	0.0	0.3	20.1	11.5	3.9	1.1	6.2	20.6	5.2	7.1	3.2	0.1	1.7	25.5	4.8	22.7	15.4	3.8	21.4	17.7	8.2	9.1	18.7	7.0	10.3	3.0	1.4	8.2	8.2	3.9	0.4	41.5	0.0	2.7	1.2	12.2	9.8	1.4	1.7	3.7	5.5	33.7	0.0	0.0	1.5	13.5	20.0	33.6	0.0	0.0	12.0	17.5	2.9	20.3	21.2	5.9	4.9	5.1	11.8	0.0	0.0	0.9	3.0	0.0	11.3	0.0	1.0	6.5	7.2	0.1	0.0	2.8	7.0	2.2	0.0	2.1
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	HPA023544	Approved					NA	NA					"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	0.4	5.2	0.5	0.4	0.8	0.0	2.0	1.2	0.9	18.9	0.6	2.4	43.3	0.1	2.2	37.8	38.3	6.0	6.2	1.1	0.6	0.1	0.2	0.1	48.7	0.1	1.0	0.5	1.2	0.1	1.8	0.9	2.5	0.9	4.8	0.0	4.3	9.8	19.2	0.8	34.2	0.3	1.6	0.5	0.1	18.0	1.0	1.1	0.7	31.9	35.9	31.9	6.2	13.1	0.2	1.5	0.5	0.5	0.1	0.4	0.0	4.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.6	0.0	3.2	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	16.8	0.0	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	19.3	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.3	0.0	1.1	0.2	0.2	0.0	0.0	0.1	0.1	1.5	0.2	0.0	0.5	0.8	1.2	0.9	0.6	0.1	1.0	0.5	0.9	1.1	77.4	116.2	6.7	13.0	9.8	20.8	2.0	10.2	38.8	34.2	3.5	7.9	3.8	0.0	3.4	0.5	2.9	2.7	0.0	4.8	0.6	5.2	5.8	8.1	1.7	1.1	6.4	20.8	8.6	5.1	0.0	3.1	5.8	15.1	1.8	3.4	4.1	3.3	4.2	3.5	0.3	2.6	0.0	2.7	2.8	2.3	15.7	3.1	10.1	2.3	23.7
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114344	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 151.5;gallbladder: 80.4"	"Cell type enhanced"	"Detected in many"	18	"Ductal cells: 151.4;Exocrine glandular cells: 106.5;Pancreatic endocrine cells: 346.5;Urothelial cells: 98.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	8	"HaCaT: 11.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.1	0.6	0.1	8.4	0.3	0.0	0.1	0.1	0.2	5.1	3.2	0.2	151.5	0.3	0.4	0.8	10.9	0.0	80.4	0.3	0.1	0.0	0.3	0.8	1.2	0.1	0.1	0.1	0.2	0.8	0.0	0.1	0.2	0.2	3.4	1.4	0.4	7.3	1.2	0.6	2.1	3.5	0.6	0.1	0.1	14.9	0.5	0.1	0.1	29.0	6.1	6.6	20.4	9.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	11.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.3	0.2	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	44.7	41.2	0.0	1.9	1.6	0.4	1.6	68.8	21.4	37.5	0.0	0.0	0.0	0.0	151.4	0.5	0.0	4.3	0.0	106.5	0.0	0.5	3.8	30.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.9	0.0	9.0	4.1	0.1	346.5	4.2	0.0	0.0	0.3	0.0	3.1	0.7	0.3	1.6	0.0	0.0	2.1	98.5
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 117.6;Erythroid cells: 70.0;Hepatocytes: 219.3;Proximal tubular cells: 85.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 4.4;Hep G2: 4.8;Karpas-707: 5.8;U-266/70: 6.1"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.2	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.5	1.9	0.8	0.7	0.0	0.1	4.4	0.0	0.0	0.0	1.5	2.8	0.7	2.6	4.8	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.5	5.8	0.0	2.6	0.9	0.9	0.7	1.1	1.0	0.9	0.3	3.1	0.0	1.9	1.2	1.8	0.5	1.5	0.2	0.3	3.9	0.3	0.4	0.4	1.3	1.3	0.2	6.1	0.4	0.4	0.8	1.9	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6	0.0	0.0	14.9	1.1	1.4	1.0	6.5	20.4	0.0	0.0	7.0	0.0	0.0	18.3	1.0	17.0	0.0	117.6	70.0	2.1	2.2	0.2	1.1	9.2	219.3	0.1	3.2	2.4	11.6	8.2	39.1	0.6	0.0	1.7	0.0	32.3	13.8	1.4	42.1	0.4	85.9	2.0	0.0	0.1	0.7	0.4	4.0	0.0	3.8	23.4	1.1
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.3	19.7	2.8	24.6	43.6	62.7	13.1	16.2	27.8	14.5	29.0	11.9	70.3	15.6	23.1	23.4	21.9	41.6	10.8	25.3	12.7	30.0	11.7	12.7	14.8	18.6	30.1	15.3	20.8	56.5	31.2	16.7	11.9	21.7	38.5	20.5	17.8	19.1	38.8	21.1	15.6	27.8	6.5	53.4	29.9	13.5	0.4	30.8	50.2	15.1	11.4	15.6	29.7	48.4	24.6	17.7	23.3	21.5	22.7	7.9	7.3	20.6	13.7	32.7	15.3	3.5	28.6	61.8	16.2	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8	65.5	100.3	104.0	135.2	101.4	10.8	146.0	216.6	120.5	84.2	115.1	11.8	257.6	247.1	119.7	471.4	96.3	424.2	23.3	105.8	108.4	95.9	76.6	140.9	263.3	268.7	7.9	147.4	136.2	267.9	923.0	67.3	177.0	143.4	164.1	202.4	80.8	97.6	394.4	47.7	486.1	13.7	84.1	117.9	6.2	8.8	101.8	153.7	238.2	288.1	173.8
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.4;HSkMC: 41.0"									"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		930000	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	13.0	13.3	15.5	41.4	2.5	8.2	14.5	7.6	9.7	2.3	0.0	0.3	8.8	20.6	6.2	0.0	1.0	0.0	9.9	0.5	0.3	4.7	0.1	3.1	10.5	0.4	8.7	41.0	0.3	11.3	0.0	20.5	5.4	3.9	1.3	0.2	16.5	0.1	6.3	8.1	2.4	0.2	11.1	7.9	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	8.1	13.2	2.3	0.1	8.4	0.4	12.1	0.6	4.1	6.0	0.5	12.7	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9	0.0	3.7	1.5	1.9	4.2	1.5	56.8	2.5	17.4	20.5	3.5	0.0	0.3	0.0	0.1	1.2	2.4	0.3	0.0	0.0	0.2	3.3	0.6	2.3	0.6	1.2	3.2	0.0	1.3	1.5	6.8	14.4	1.0	5.0	0.0	0.8	11.0	0.1	0.0	9.9	0.8	0.2	6.5	3.1	0.4	0.4	2.5	0.5	4.3	0.4	0.7
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 147.7;Proximal tubular cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.5	6.1	6.9	5.1	28.0	21.4	2.6	8.4	14.7	9.1	11.1	3.8	20.5	5.5	17.3	13.0	7.4	8.5	8.2	13.6	9.9	11.2	6.2	7.4	5.4	8.7	36.2	2.8	4.9	24.8	20.2	11.9	23.0	24.5	12.3	10.5	7.5	7.8	16.6	10.8	4.5	5.7	1.7	28.9	8.5	6.4	5.6	10.2	21.4	5.5	5.8	5.1	10.9	4.1	18.5	9.5	13.0	7.2	9.2	7.5	4.6	13.7	3.6	11.2	5.5	4.9	18.7	10.7	8.8	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1	11.9	21.7	21.7	27.4	5.3	24.1	30.3	43.3	28.1	12.5	47.1	17.7	37.1	101.2	42.9	1.5	21.1	59.4	0.0	21.2	21.2	16.6	28.0	17.3	147.7	52.8	33.4	8.6	31.3	25.4	3.2	20.1	21.3	20.3	60.5	44.3	33.5	28.9	49.2	23.0	159.0	20.1	6.5	18.9	4.1	3.3	5.6	34.6	15.2	47.0	22.5
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 111.3;granulocytes: 138.1;Hepatocytes: 197.3;Peritubular cells: 89.5;Proximal tubular cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.6;SiHa: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	20.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.6	39.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3	0.0	5.5	0.0	0.4	4.8	1.0	111.3	38.2	21.4	3.4	5.2	3.9	0.3	53.0	15.6	0.1	11.3	8.0	0.0	2.5	0.7	11.2	0.6	138.1	197.3	1.4	14.3	0.0	4.9	4.7	0.4	42.6	1.3	6.8	0.0	2.9	25.5	4.7	8.0	89.5	130.3	0.7	12.9	15.6	0.0	0.1	3.4	0.3	4.3	3.9	0.3
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Cell type enhanced"	"Detected in some"	11	"Distal tubular cells: 1.7;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Group enriched"	"Detected in some"	93	"HL-60: 218.1;NB-4: 285.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	285.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	1.2	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
NQO1	"DHQU, DIA4, DTD, NMOR1, QR1"	ENSG00000181019	"NAD(P)H quinone dehydrogenase 1"	P15559	16	69706996-69726951	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 142.1"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 149.4;OE19: 264.4;SiHa: 169.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007308, CAB012421"	Enhanced		Supported	Cytosol		NA	NA		310000	Cytosol		"CAB012421: , HPA007308: AB_1079501"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-3)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.27e-1)"	31.3	24.2	12.8	6.4	20.7	0.6	77.1	2.7	9.1	7.6	23.2	7.8	5.7	29.5	3.9	8.6	36.3	8.2	77.2	9.3	9.9	7.5	44.7	1.2	17.2	6.9	11.3	6.0	3.7	2.5	7.0	3.7	3.5	25.5	9.8	20.8	20.2	10.5	7.6	7.6	2.3	17.7	22.7	10.4	6.0	142.1	3.8	4.9	0.1	25.7	69.7	16.2	21.2	18.9	5.2	3.2	0.9	3.2	15.1	12.3	4.4	13.1	149.4	12.5	55.9	31.2	45.3	4.7	22.3	40.0	23.0	35.6	18.1	85.3	0.4	26.5	115.2	40.2	13.8	4.8	25.1	11.8	5.3	0.2	0.6	37.0	131.8	41.5	3.1	10.7	10.6	15.9	39.9	4.6	34.6	57.0	1.0	5.4	0.9	122.9	42.6	0.6	5.7	6.6	264.4	14.5	1.0	2.6	6.1	45.9	47.9	4.5	1.0	169.7	24.1	99.3	14.9	39.0	10.5	38.6	23.2	9.6	8.7	17.5	0.7	2.9	0.6	29.7	1.7	114.7	0.6	3.2	0.2	5.7	0.3	2.9	5.2	6.6	7.2	3.2	2.1	2.1	4.7	0.9	15.1	0.3	1.2	12.3	4.4	12.8	20.7	2.7	9.1	9.9	7.5	11.3	6.0	25.5	4.9	23.8	13.4	1.4	19.5	4.6	4.0	4.5	203.8	259.6	28.4	40.1	3.9	2.1	124.3	22.1	0.3	55.5	72.0	0.0	134.0	3.1	13.1	25.1	19.6	3.2	12.5	3.2	19.5	31.9	3.3	0.9	23.3	8.2	16.9	222.8	60.8	7.6	63.7	49.1	11.3	24.5	10.7	6.5	17.6	0.2	1.5	4.0	1.6	4.4	33.4	25.4
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	52.1	16.0	26.6	29.5	103.2	50.5	22.5	106.5	36.3	44.5	31.6	30.2	35.1	33.9	34.1	87.2	16.4	30.5	34.8	34.3	36.2	29.8	32.1	22.5	27.4	34.1	58.2	23.5	7.4	41.8	34.8	24.4	34.2	28.0	43.6	14.2	50.0	7.0	50.5	10.7	15.9	31.0	58.5	28.7	99.6	19.1	30.8	34.6	66.6	11.9	12.4	23.0	36.7	43.2	24.4	40.0	36.5	33.2	29.3	17.3	19.9	26.2	28.9	10.6	15.7	27.9	20.8	20.5	15.8	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1	163.8	131.5	140.0	350.9	209.2	31.5	477.5	249.7	195.4	161.5	263.5	27.5	589.1	729.5	163.2	193.0	183.6	264.7	256.9	175.5	640.5	290.3	337.6	341.6	875.0	302.1	42.9	136.4	174.3	152.8	441.3	315.2	140.2	173.7	230.0	253.4	390.8	159.2	306.9	391.7	634.8	41.0	181.1	254.2	113.1	58.3	231.0	805.7	161.9	278.6	280.8
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0"									HPA002904	Enhanced					NA	NA					"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.1	1.3	2.8	0.9	20.3	10.5	15.0	8.4	3.0	2.3	2.1	7.4	3.9	7.7	1.6	6.1	1.8	1.0	1.6	1.4	2.3	0.6	3.2	0.4	4.7	2.1	1.1	1.1	4.4	3.4	0.2	1.4	0.8	1.5	3.4	0.6	0.4	8.1	6.0	0.9	0.6	1.0	1.0	0.0	1.9	1.1	1.6	25.9	5.7	6.0	2.0	1.7	1.7	3.0	0.9	4.8	1.3	0.4	6.0	9.1	0.5	11.6	1.3	43.0	0.0	18.0	2.1	0.9	2.4	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3	11.9	2.1	1.5	1.7	0.8	3.1	5.0	2.5	0.0	1.2	1.8	0.0	34.3	0.0	6.9	0.1	4.3	4.1	0.0	17.1	18.7	4.1	7.6	6.9	7.4	6.6	1.6	3.5	2.5	5.9	0.0	2.6	2.7	1.7	2.8	2.3	3.1	8.7	7.4	6.3	1.4	0.8	0.0	4.7	0.0	1.4	0.9	78.6	0.0	2.2	7.4
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28605196-28623625	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 529.7;Hepatocytes: 206.6;Paneth cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 50.6;intermediate monocyte: 39.2;myeloid DC: 22.9;neutrophil: 47.7;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 22.9;granulocytes: 47.7;monocytes: 50.6"	"Group enriched"	"Detected in many"	4	"EFO-21: 42.4;Hep G2: 83.9"									"HPA049500, HPA051051"	Supported					NA	NA		3700000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	10.2	36.1	12.0	7.2	15.4	9.3	5.7	15.8	19.8	4.6	21.4	4.5	15.5	54.2	3.7	14.4	3.1	6.6	5.4	9.7	14.7	10.4	11.0	98.1	26.7	8.4	9.2	14.9	3.5	9.6	6.7	10.0	5.6	10.3	3.7	17.5	12.2	11.5	22.5	4.9	1.4	41.1	5.2	6.3	23.2	7.2	5.1	4.6	4.0	13.4	2.6	3.7	6.3	2.2	0.3	22.9	47.7	50.6	0.9	1.5	19.3	1.6	0.6	0.8	2.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	10.5	0.2	42.4	0.0	0.4	0.6	0.8	2.9	0.1	0.3	7.5	2.8	3.2	83.9	5.0	0.0	3.2	0.2	0.2	0.1	0.0	0.1	0.8	3.2	1.1	1.4	0.8	9.9	0.2	2.2	0.7	0.4	0.0	3.1	0.3	5.5	0.7	0.9	2.6	0.2	0.7	13.8	0.3	3.9	8.2	8.1	5.5	0.2	2.1	0.2	0.1	3.3	1.9	0.4	0.7	15.5	0.0	4.9	50.6	0.9	0.6	39.2	0.7	0.3	0.6	0.5	22.9	0.1	0.9	0.6	47.7	0.9	22.3	1.7	1.5	19.3	12.0	15.4	15.8	19.8	14.7	10.4	9.2	14.9	10.3	4.6	178.6	77.7	8.2	7.0	1.0	16.8	12.3	43.3	46.8	22.7	15.7	9.8	2.0	109.5	9.9	94.0	8.0	529.7	0.0	18.0	1.1	16.2	2.7	47.5	206.6	32.1	7.9	19.1	43.0	192.8	26.4	47.5	39.4	1.7	16.2	39.6	65.5	6.2	294.5	32.5	16.8	3.5	19.4	9.9	20.2	4.5	0.3	1.6	7.5	70.4	5.8
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597109	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.5;liver: 26.2;seminal vesicle: 24.2"	"Cell type enriched"	"Detected in many"	5	"Enterocytes: 311.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.9;EFO-21: 8.8;Hep G2: 32.6"									"HPA049500, HPA051051"	Supported					NA	NA					"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.0	1.9	0.6	2.5	1.0	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1.0	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.7	0.6	0.5	0.1	0.3	6.9	0.7	0.0	0.1	0.0	1.3	3.0	0.2	8.8	0.2	0.1	1.2	0.3	0.5	0.2	0.4	0.4	1.3	1.7	32.6	0.5	1.1	1.3	0.2	0.6	0.5	0.1	0.4	0.2	0.6	0.7	1.5	0.1	1.6	0.2	2.1	1.0	0.3	0.3	1.3	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.6	0.0	1.1	3.2	0.6	0.4	1.7	1.0	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7.0	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1.0	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2	26.8	10.8	0.5	0.5	0.2	0.2	2.0	0.0	2.7	9.1	3.5	0.0	0.1	13.3	5.9	0.1	0.8	311.3	0.0	4.1	0.2	2.6	0.2	11.5	43.6	1.3	0.0	2.9	10.4	7.9	0.8	1.4	0.2	0.0	0.0	6.8	3.7	5.0	59.6	1.4	5.6	0.5	0.0	0.4	0.7	0.1	0.1	0.2	0.0	9.8	0.9
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.8;intestine: 31.0"	"Cell type enhanced"	"Detected in many"	6	"Paneth cells: 24.9;Undifferentiated cells: 21.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	10	"classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.2;monocytes: 27.8"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 40.0;Hep G2: 54.8"									"HPA049500, HPA051051"	Supported					NA	NA		3200000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	1.4	3.8	5.6	4.3	4.9	7.5	2.5	14.0	6.3	2.1	6.7			31.0	2.5	4.5	4.0	3.7	2.0	1.7	5.6	5.2	6.6	10.1	3.8	3.2	4.3		2.9	4.3	8.1	8.0	3.0		5.8	6.1		5.3	5.2	1.5	5.6	17.9	4.0	3.4	5.7	2.7	2.1			6.4		5.8	3.6	2.4	1.5	16.2	1.4	27.8	0.4	2.0	11.2	4.9	10.3	10.3	7.1	9.4	5.4	13.7	5.5	4.6	5.5	6.2	4.3	40.0	5.0	29.0	5.2	3.7	12.9	10.6	4.3	5.4	4.6	7.6	4.0	14.1	54.8	3.8	3.3	9.4	7.6	7.0	6.0	2.1	12.3	6.3	7.0	1.2	31.6	3.7	15.2	2.6	20.9	6.0	10.7	6.0	11.2	4.1	9.1	7.1	4.4	4.0	5.3	1.5	16.2	2.4	3.3	6.1	7.4	2.4	10.9	5.3	8.0	3.2	9.4	8.7	3.1	3.9	5.8	6.4	1.4	27.8	0.1	2.0	24.0	0.3	1.5	0.3	0.6	16.2	0.3	0.3	0.3	0.4	0.4	11.1	0.2	0.3	11.2											11.9	8.1	5.2	1.9	1.8	5.0	1.5	5.1	2.7	11.4	0.0	7.9	4.6	0.0	2.5	1.0	4.5	15.0	0.0	3.6	2.1	2.0	2.8	1.1	2.4	1.3	1.6	1.2	3.1	3.5	0.4	0.9	2.8	1.7	3.6	10.7	2.6	4.3	24.9	1.8	0.3	5.7	0.0	2.0	0.6	0.2	2.4	2.5	3.2	21.1	1.6
SULT1A4		ENSG00000213648	"Sulfotransferase family 1A member 4"	P0DMN0	16	29459889-29464976	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 16.7;intestine: 38.8"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.0;Club cells: 6.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	13	"classical monocyte: 11.3;intermediate monocyte: 16.7;myeloid DC: 11.3;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 11.3;monocytes: 16.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 31.5;EFO-21: 26.2;HEL: 21.4;Hep G2: 69.1;Karpas-707: 41.2"									"HPA049500, HPA051051"	Supported					NA	NA					"HPA049500: AB_2680796, HPA051051: AB_2681327"										"unprognostic (4.14e-2)"				"unprognostic (1.04e-1)"				2.7	0.7	3.3	2.0	1.6	0.9	2.0	4.3	2.6	3.0	8.1			38.8	1.2	0.0	0.3	1.7	1.6	1.7	2.8	1.6	2.8	1.7	3.4	2.9	1.5		0.9	0.6	0.0	1.8	2.4		2.2	7.6		1.8	0.0	0.7	5.2	25.9	2.7	1.1	3.3	3.2	1.1			3.4		2.1	0.1	1.0	0.6	11.3	0.8	16.7	0.2	0.6	2.4	4.1	4.1	1.3	0.1	0.1	1.4	1.8	0.4	0.7	0.1	0.1	2.4	31.5	0.2	26.2	0.2	0.6	4.5	1.7	0.4	0.1	1.5	2.3	21.4	2.8	69.1	0.6	0.7	3.0	0.0	0.0	2.0	0.0	0.3	4.9	0.0	4.3	41.2	0.1	2.0	0.4	3.2	0.9	12.0	0.8	1.7	0.6	1.1	3.0	2.9	0.9	2.3	0.0	6.3	0.0	0.5	1.3	0.0	8.6	0.8	0.4	1.3	0.7	1.8	14.0	0.4	2.0	3.7	0.2	0.2	11.3	0.0	0.6	16.7	0.1	0.6	0.3	0.1	11.3	0.5	0.3	0.1	0.8	0.2	5.0	0.2	0.3	2.4											6.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	1.4	6.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171877	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"adrenal gland: 83.5;brain: 41.4"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	6	"hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"PC-3: 35.9;SK-BR-3: 12.8"	"Region enhanced"	"Detected in many"		"olfactory region: 220.1"	"Region enriched"	"Detected in many"	19	"midbrain: 692.0"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	1.3	83.5	0.0	0.3	5.4	0.2	0.2	0.0	0.7	1.8	0.2	6.2	0.0	0.2	0.3	0.3	0.2	0.3	0.4	0.2	0.3	15.5	0.2	0.2	0.2	0.2	41.4	0.0	0.3	0.3	0.2	0.2	0.9	41.2	0.6	0.2	0.3	0.2	2.0	0.2	0.5	0.4	0.2	0.0	0.3	0.2	0.3	1.5	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	35.9	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.3	15.5	41.4	0.0	41.2	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.1
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374223-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"thyroid gland: 411.3"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 2.2;Early spermatids: 3.0;Endothelial cells: 1.1;Late spermatids: 3.8;Peritubular cells: 3.5"	"Cancer enriched"	"Detected in some"	364	"thyroid cancer: 188.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"memory CD4 T-cell: 5.1;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 5.1"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.3;RPMI-8226: 6.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007987, CAB009587"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB009587: , HPA007987: AB_1080270"	"unprognostic (1.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.98e-3)"	"unprognostic (7.10e-3)"	1.1	0.0	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.5	0.0	0.2	0.1	0.1	7.1	0.2	0.1	0.1	0.1	411.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	5.1	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	3.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 175.5"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	864	"SK-MEL-30: 86.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	175.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.0
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell type enriched"	"Detected in some"	19	"Melanocytes: 2358.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 177.7"	"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		16000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.7	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2	0.0	0.0	0.0	0.0	82.0	0.6	39.7	0.0	0.0	0.0	3.5	2.0	0.0	122.7	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.3	0.0	2358.5	0.0	0.0	15.4	0.0	0.0	0.0	0.8	1.3	0.0	3.1	0.5	0.7	14.6	0.0	0.0	0.0	0.1
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 83.9"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;OE19: 35.4;RT4: 19.3"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.1	0.2	0.1	1.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.3	35.4	3.6	0.0	0.1	0.3	0.0	19.3	0.1	0.2	1.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.7	6.8	1.8	0.0	0.0	0.0	0.2	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.9	0.0	83.9	0.0	0.0	0.0	1.3	3.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 16.7"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Group enriched"	"Detected in some"	8	"Club cells: 4.5;Hepatocytes: 10.5"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2"															NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A5	UGT1E	ENSG00000240224	"UDP glucuronosyltransferase family 1 member A5"	P35504	2	233712992-233773299	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.7;intestine: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;RT4: 1.6"															NA	NA												"unprognostic (2.18e-3)"							"unprognostic (1.36e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	11.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 40.4;OE19: 160.5"									"CAB009819, HPA054065"	Enhanced					NA	NA					"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	11.3	0.0	0.1	40.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	160.5	0.0	0.0	0.0	0.0	0.4	20.4	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.3	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	37.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.6	0.0	19.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	2.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 8.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	14	"SiHa: 50.6"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	50.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	8.4
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 221.7"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"Hep G2: 16.1"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.7	0.0	0.0	0.0	1.3	4.7	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 12.7"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.2;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1"									HPA045108	Approved					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	168.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	1.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	134.4	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.5
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Cell type enriched"	"Detected in single"	178	"Cholangiocytes: 17.8"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	10	"Daudi: 7.1;NB-4: 6.5"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
